A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans ; volume:45 ; number:1 ; year:2017 ; pages:88-107
Cellular physiology and biochemistry ; 45, Heft 1 (2017), 88-107
- Creator
-
Yi, Min
Li, Hekai
Wu, Zhiye
Yan, Jianyun
Liu, Qicai
Ou, Caiwen
Chen, Minsheng
- DOI
-
10.1159/000486225
- URN
-
urn:nbn:de:101:1-2018021417790
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yi, Min
- Li, Hekai
- Wu, Zhiye
- Yan, Jianyun
- Liu, Qicai
- Ou, Caiwen
- Chen, Minsheng
Other Objects (12)
Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension
Improving metabolic control in humans by intranasal neuropeptide administration
Solubilization and characterization of active neuropeptide-Y receptors from rabbit kidney
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Investigations on neuropeptide Y and histamine receptors by fluorescence-based and radiochemical methods
Investigations on neuropeptide Y and histamine receptors by fluorescence-based and radiochemical methods
Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension
Improving metabolic control in humans by intranasal neuropeptide administration
Solubilization and characterization of active neuropeptide-Y receptors from rabbit kidney
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Investigations on neuropeptide Y and histamine receptors by fluorescence-based and radiochemical methods
Investigations on neuropeptide Y and histamine receptors by fluorescence-based and radiochemical methods
Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension
Improving metabolic control in humans by intranasal neuropeptide administration
Solubilization and characterization of active neuropeptide-Y receptors from rabbit kidney
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Investigations on neuropeptide Y and histamine receptors by fluorescence-based and radiochemical methods